TerminatedNCT00340548
Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)
Studying Acquired Hemophilia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Daniel W McVicar, Ph.D.National Cancer Institute (NCI)
- Enrollment
- 333 enrolled
- Eligibility
- 4-100 years · All sexes
- Timeline
- 2002 – 2020
Study locations (15)
- University of California, San Diego, La Jolla, California, United States
- Childrens Hospital, Los Angeles, Los Angeles, California, United States
- St. Vincent Hospital & Health Care Center, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- Tulane University, New Orleans, Louisiana, United States
- NCI Frederick Cancer Research Center, Frederick, Maryland, United States
- Wayne State University Hutzel Hospital, Detroit, Michigan, United States
- Childrens Mercy Hospital, Kansas City, Missouri, United States
- University of Nebraska, Omaha, Nebraska, United States
- Cornell University, New York, New York, United States
- Mt. Sinai Medical Center, New York, New York, United States
- University of Oklahoma, Oklahoma City, Oklahoma, United States
- Milton Hershey Medical Center, Hershey, Pennsylvania, United States
- University of Texas, Houston, Houston, Texas, United States
- University of Texas, San Antonio, San Antonio, Texas, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00340548 on ClinicalTrials.govOther trials for Acquired Hemophilia
Additional recruiting or active studies for the same condition.